Drug intelligence / Profile preview

Xitongkang

Development stage: Unknown
Lead developer: Liaoning Provincial Health Commission

Overview

Xitongkang is a Traditional Chinese Medicine (TCM) undergoing clinical investigation for the treatment of knee osteoarthritis, specifically targeting cases characterized by kidney deficiency and blood stasis syndrome. As a TCM, it is likely composed of a blend of natural ingredients, typically herbs, formulated to restore balance within the body according to traditional Chinese medical principles.

Other names: 膝痛康

Beyond the preview

Go deeper on Xitongkang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xitongkang.

Explore the full profile